Acute lymphoblastic leukemia relapse after CD19‐targeted chimeric antigen receptor T cell therapy von Wang, Jiasheng, Hu, Yongxian, Huang, He

Volltext

Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019 von Zhou, Linghui, Yu, Qin, Wei, Guoqing, Wang, Linqin, Huang, Yue, Hu, Kejia, Hu, Yongxian, Huang, He

Volltext

Biomarkers for Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: Prospects for Personalized Management and Prognostic Prediction von Hong, Ruimin, Hu, Yongxian, Huang, He

Volltext

Cell subsets and cytokine dynamics in cerebrospinal fluid after CAR-T cell therapy for B-cell acute lymphoblastic leukemia with central nervous system involvement von Hu, Kejia, Wang, Yiyun, Teng, Xinyi, Hu, Yongxian, Huang, He

Volltext

Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions von Zhang, Li, Tian, Lin, Dai, Xiaoyang, Yu, Hua, Wang, Jiajia, Lei, Anhua, Zhu, Mengmeng, Xu, Jianpo, Zhao, Wei, Zhu, Yuqing, Sun, Zhen, Zhang, Hao, Hu, Yongxian, Wang, Yanlin, Xu, Yuming, Church, George M., Huang, He, Weng, Qinjie, Zhang, Jin

Volltext

Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches von Gu, Tianning, Zhu, Meng, Huang, He, Hu, Yongxian

Volltext

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies von Zhu, Feng, Wei, Guoqing, Liu, Yandan, Zhou, Houli, Wu, Wenjun, Yang, Luxin, Huang, He, Hu, Yongxian

Volltext

Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy von Feng, Jingjing, Shao, Mi, Hu, Yongxian, Huang, He

Volltext

Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy von Hong, Ruimin, Zhao, Houli, Wang, Yiyun, Chen, Yu, Cai, Hongliu, Hu, Yongxian, Wei, Guoqing, Huang, He

Volltext

Successful chimeric antigen receptor T cells therapy in extramedullary relapses of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation von Zhang, Hao, Hu, Yongxian, Wei, Guoqing, Wu, Wenjun, Huang, He

Volltext

Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia von Hu, Yongxian, Wu, Zhao, Luo, Yi, Shi, Jimin, Yu, Jian, Pu, Chengfei, Liang, Zuyu, Wei, Guoqing, Cui, Qu, Sun, Jie, Jiang, Jing, Xie, Jue, Tan, Yamin, Ni, Wanmao, Tu, Jifang, Wang, Jinping, Jin, Aiyun, Zhang, Hao, Cai, Zhen, Xiao, Lei, Huang, He

Volltext

Waldenström macroglobulinemia: a challenging case treated with anti-CD19 CAR-T cell therapy von Yang, Yang, Gu, Xiaolin, He, Jingsong, Hu, Yongxian, Cai, Zhen

Volltext

Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies von Zhu, Feng, Wei, Guoqing, Zhang, Mingming, Zhao, Houli, Wu, Wenjun, Yang, Luxin, Hu, Yongxian, Huang, He

Volltext

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies von Hu, Yongxian, Li, Jingjing, Ni, Fang, Yang, Zhongli, Gui, Xiaohua, Bao, Zhiwei, Zhao, Houli, Wei, Guoqing, Wang, Yiyun, Zhang, Mingming, Hong, Ruimin, Wang, Linqin, Wu, Wenjun, Mohty, Mohamad, Nagler, Arnon, Chang, Alex H., van den Brink, Marcel R. M., Li, Ming D., Huang, He

Volltext

Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis von Yang, Luxin, Tan, Yamin, Shi, Jimin, Zhao, Yanmin, Yu, Jian, Hu, Yongxian, Lai, Xiaoyu, Yang, Yang, Huang, He, Luo, Yi

Volltext

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy von Hu, Yongxian, Sun, Jie, Wu, Zhao, Yu, Jian, Cui, Qu, Pu, Chengfei, Liang, Bin, Luo, Yi, Shi, Jimin, Jin, Aiyun, Xiao, Lei, Huang, He

Volltext

CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial von Shao, Mi, Yu, Qin, Teng, Xinyi, Guo, Xin, Wei, Guoqing, Xu, Huijun, Cui, Jiazhen, Chang, A. H., Hu, Yongxian, Huang, He

Volltext

Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with... von Ni, Fang, Yin, Elaine Tan Su, Zhou, Linghui, Zhao, Houli, Luo, Yi, Shi, Jimin, Hu, Yongxian, Huang, He

Volltext

Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies von Zu, Cheng, Li, Wenxiao, Zhang, Mingming, Dong, Yetian, Fu, Shan, Feng, Jingjing, Hong, Ruimin, Huang, He, Hu, Yongxian, Su, Junwei

Volltext

Special issue: CAR‐T cell therapy for hematological malignancies von Hu, Yongxian, Huang, He

Volltext